Science Explorer Back to mapMap
Discussion
Company · Watertown · United States

Tetraphase Pharmaceuticals (United States)

tphase.comROR OpenAlex
Research works
57
▼ 93% vs 2018-21
Citations
2.6k
45.2 per fractional work
Top-10% rate
38.7%
all institutions 10.0%
Open access
58%
world 40%
International
16%
world 18%
Tetraphase Pharmaceuticals (United States)

Not ranked overall: Tetraphase Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Tetraphase Pharmaceuticals (United States) work in?

In all years, 42% of research at Tetraphase Pharmaceuticals (United States) is in Life Sciences, 37% in Health Sciences. Its largest fields are Medicine (36%), Biochemistry, Genetics and Molecular Biology (36%), Chemistry (7%). It does 2.3× the world's share of Life Sciences.

Life Sciences: 24 fractional works · 41.8% of its workBiochemistry, Genetics and Molecular Biology: 20 fractional works · 35.5% of its workMolecular Medicine: 10 fractional works · 17.2% of its workMolecular Biology: 8 fractional works · 13.5% of its workEndocrinology: 1 fractional works · 2.0% of its workClinical Biochemistry: 1 fractional works · 1.5% of its workGenetics: 0 fractional works · 0.8% of its workBiotechnology: 0 fractional works · 0.3% of its workCancer Research: 0 fractional works · 0.3% of its workImmunology and Microbiology: 3 fractional works · 5.2% of its workApplied Microbiology and Biotechnology: 2 fractional works · 3.9% of its workImmunology: 1 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.8% of its workPharmaceutical Science: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 0.3% of its workFood Science: 0 fractional works · 0.3% of its workHealth Sciences: 21 fractional works · 36.9% of its workMedicine: 21 fractional works · 36.4% of its workPharmacology: 8 fractional works · 13.4% of its workInfectious Diseases: 4 fractional works · 6.9% of its workEpidemiology: 3 fractional works · 5.9% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 2.3% of its workOncology: 1 fractional works · 1.8% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.8% of its workPulmonary and Respiratory Medicine: 1 fractional works · 1.8% of its workEmergency Medicine: 1 fractional works · 1.5% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.6% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 0.3% of its workGeneral Health Professions: 0 fractional works · 0.3% of its workVeterinary: 0 fractional works · 0.2% of its workPhysical Sciences: 12 fractional works · 20.7% of its workChemistry: 4 fractional works · 6.9% of its workOrganic Chemistry: 2 fractional works · 4.3% of its workInorganic Chemistry: 1 fractional works · 2.1% of its workAnalytical Chemistry: 0 fractional works · 0.6% of its workEnvironmental Science: 4 fractional works · 6.4% of its workPollution: 3 fractional works · 5.8% of its workEcology: 0 fractional works · 0.6% of its workEngineering: 2 fractional works · 3.2% of its workBiomedical Engineering: 1 fractional works · 1.4% of its workOcean Engineering: 0 fractional works · 0.9% of its workElectrical and Electronic Engineering: 0 fractional works · 0.7% of its workMedia Technology: 0 fractional works · 0.3% of its workMaterials Science: 2 fractional works · 3.1% of its workMaterials Chemistry: 1 fractional works · 2.2% of its workBiomaterials: 0 fractional works · 0.9% of its workPhysics and Astronomy: 0 fractional works · 0.5% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workComputer Science: 0 fractional works · 0.3% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.3% of its workMathematics: 0 fractional works · 0.3% of its workStatistics and Probability: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 0.6% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.3% of its workEconomics and Econometrics: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 0.3% of its workHealth: 0 fractional works · 0.3% of its workALL ITS WORKTetraphasePharmaceuticals…57fractional works, all years
Life Sciences42%Physical Sciences21%Health Sciences37%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 16 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2035.5%
    2. Immunology and Microbiology35.2%
    3. Pharmacology, Toxicology and Pharmaceutics00.8%
    4. Agricultural and Biological Sciences00.3%
    1. Medicine2136.4%
    2. Health Professions00.3%
    3. Veterinary00.2%
    1. Chemistry46.9%
    2. Environmental Science46.4%
    3. Engineering23.2%
    4. Materials Science23.1%
    5. Physics and Astronomy00.5%
    6. Computer Science00.3%
    7. Mathematics00.3%
    1. Economics, Econometrics and Finance00.3%
    2. Social Sciences00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Tetraphase Pharmaceuticals (United States)?

Ranked on the quality score, Joyce A. Sutcliffe, Trudy H. Grossman and Melanie Olesky lead among researchers whose main affiliation is Tetraphase Pharmaceuticals (United States).

  1. 1 Joyce A. Sutcliffe United States · #509,823 worldwide 7.1k citations · 88 works
  2. 2 Trudy H. Grossman United States · #1,465,459 worldwide 4.7k citations · 53 works
  3. 3 Melanie Olesky United States · #1,581,005 worldwide 1.1k citations · 26 works
  4. 4 Corey Fyfe United States · #1,607,944 worldwide 1.1k citations · 22 works
  5. 5 Cuixiang Sun United States · #2,020,509 worldwide 800 citations · 31 works
  6. 6 Diana K. Hunt United States · #2,258,421 worldwide 709 citations · 28 works
  7. 7 Roger B. Clark United States · #2,496,960 worldwide 663 citations · 61 works
  8. 8 Xiao-Yi Xiao United States · #3,220,386 worldwide 500 citations · 18 works
  9. 9 Sergey Izmailyan United States · #3,274,091 worldwide 207 citations · 15 works
  10. 10 Chi-Li Chen United States · #4,125,114 worldwide 438 citations · 23 works
All ranked researchers at Tetraphase Pharmaceuticals (United States)

What are the most cited papers from Tetraphase Pharmaceuticals (United States)?

The most cited paper from Tetraphase Pharmaceuticals (United States) is "Tetracycline Antibiotics and Resistance" (Trudy H. Grossman, 2016), with 755 citations. Next come "Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial" (280) and "Resistance to Macrolide Antibiotics in Public Health Pathogens" (251).

Most cited papers
#PaperReleasedCitations
1 Tetracycline Antibiotics and Resistance Trudy H. Grossman · Cold Spring Harbor Perspectives in Medicine Open access 17 Mar 2016 755
2 Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial Joseph S. Solomkin, David Clay Evans, Algirdas Šlepavičius et al. · JAMA Surgery 16 Nov 2016 280
3 Resistance to Macrolide Antibiotics in Public Health Pathogens Corey Fyfe, Trudy H. Grossman, Kathy Kerstein et al. · Cold Spring Harbor Perspectives in Medicine Open access 15 Aug 2016 251
4 Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens Joyce A. Sutcliffe, William J. O’Brien, Corey Fyfe et al. · Antimicrobial Agents and Chemotherapy Open access 27 Aug 2013 239
5 IGNITE4: Results of a Phase 3, Randomized, Multicenter, Prospective Trial of Eravacycline vs Meropenem in the Treatment of Complicated Intraabdominal Infections Joseph S. Solomkin, Jānis Gardovskis, Kenneth R Lawrence et al. · Clinical Infectious Diseases Open access 12 Dec 2018 220
All 81 most cited papers, with filters and sorting

Which keywords describe research at Tetraphase Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Antibiotic Resistance, ESKAPE Pathogens, Multidrug-Resistant Bacteria, Antimicrobial Resistance, Epidemiology, Antibiotic Pharmacokinetics, Critically Ill Patients and Antibiotics.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Antibiotic Resistance14▲ 61×6 topics
  2. ESKAPE Pathogens10▲ 324×1 topic
  3. Multidrug-Resistant Bacteria10▲ 324×1 topic
  4. Antimicrobial Resistance10▲ 67×4 topics
  5. Epidemiology9▲ 3.9×13 topics
  6. Antibiotic Pharmacokinetics6▲ 240×1 topic
  7. Critically Ill Patients6▲ 240×1 topic
  8. Antibiotics4▲ 84×2 topics
  9. Microbial Communities4▲ 19×2 topics
  10. Pharmaceuticals4▲ 85×2 topics
  11. Drug Resistance3▲ 19×3 topics
  12. Drug Discovery3▲ 15×3 topics
  13. Resistance Genes3▲ 150×1 topic
  14. Wastewater Contaminants3▲ 150×1 topic
  15. Chemotherapy3▲ 7.8×2 topics
  16. Synthesis3▲ 9.0×5 topics
  17. Diagnosis3▲ 4.4×5 topics
  18. Infectious Diseases3▲ 19×2 topics
  19. DNA2▲ 137×1 topic
  20. Topoisomerases2▲ 137×1 topic
  21. Virulence Factors2▲ 23×2 topics
  22. Public Health2▲ 3.0×2 topics
  23. Healthcare-Associated Infections2▲ 33×4 topics
  24. Antimicrobial Stewardship2▲ 133×1 topic
  25. Global Health2▲ 30×1 topic
  26. MRSA2▲ 105×1 topic
  27. Nanoparticles2▲ 2.7×7 topics
  28. Staphylococcus aureus2▲ 48×1 topic
  29. Foldamers2▲ 44×1 topic
  30. Peptide Synthesis2▲ 44×1 topic
  31. Biological Activities2▲ 17×1 topic
  32. Phenothiazines2▲ 186×1 topic
  33. Management2▲ 3.5×2 topics
  34. Antiretroviral Therapy2▲ 11×3 topics
  35. Cystic Fibrosis1▲ 29×3 topics
  36. Enantioselective Reactions1▲ 26×2 topics
  37. Medicinal Chemistry1▲ 6.0×3 topics
  38. Bacteremia1▲ 28×2 topics
  39. Anticancer Agents1▲ 7.3×3 topics
  40. Antibiotic Therapy1▲ 33×2 topics

Which research topics does Tetraphase Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Pregnancy-related medical research, Injury Epidemiology and Prevention, Antibiotic Resistance in Bacteria and Antibiotics Pharmacokinetics and Efficacy.

Pregnancy-related medica…0Pregnancy-related medical research: 0 fractional worksInjury Epidemiology and …0Injury Epidemiology and Prevention: 0 fractional worksAntibiotic Resistance in…0Antibiotic Resistance in Bacteria: 0 fractional worksAntibiotics Pharmacokine…0Antibiotics Pharmacokinetics and Efficacy: 0 fractional worksAntimicrobial Resistance in Staphylococcus: 0 fractional works
Public Health, Environmental and Occupational HealthMolecular MedicinePharmacologyInfectious Diseases

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Pregnancy-related medical research Public Health, Environmental and Occupational Health 0 works
  2. 2 Injury Epidemiology and Prevention Public Health, Environmental and Occupational Health 0 works
  3. 3 Antibiotic Resistance in Bacteria Molecular Medicine 0 works
  4. 4 Antibiotics Pharmacokinetics and Efficacy Pharmacology 0 works
  5. 5 Antimicrobial Resistance in Staphylococcus Infectious Diseases 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available58.3%not open41.7%

World: 40% of research is openly available.

with international co-authors15.9%domestic only84.1%

World: 18% is written across borders.

How has Tetraphase Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 93% lower than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Tetraphase Pharmaceuticals (United States) as a percentage of every work published that year, 0.0000093% in 2023.

still counting0.00010%0.00020%0.00030%Tetraphase Pharmaceuticals (United States)0.000017% in 202520102020

Fractional works of Tetraphase Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Watertown

All research institutions in Watertown

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Tetraphase Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.